Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;1(1):46-49.
doi: 10.4161/bact.1.1.13980.

Lysis from without

Affiliations

Lysis from without

Stephen T Abedon. Bacteriophage. 2011 Jan.

Abstract

In this commentary I consider use of the term "lysis from without" (LO) along with the phenomenon's biological relevance. LO originally described an early bacterial lysis induced by high-multiplicity virion adsorption and that occurs without phage production (here indicated as LO(V)). Notably, this is more than just high phage multiplicities of adsorption leading to bacterial killing. The action on bacteria of exogenously supplied phage lysin, too, has been described as a form of LO (here, LO(L)). LO(V) has been somewhat worked out mechanistically for T4 phages, has been used to elucidate various phage-associated phenomena including discovery of the phage eclipse, may be relevant to phage ecology, and, with resistance to LO (LO(R)), is blocked by certain phage gene products. Speculation as to the impact of LO(V) on phage therapy also is fairly common. Since LO(V) assays are relatively easily performed and not all phages are able to induce LO(V), a phage's potential to lyse bacteria without first infecting should be subject to at least in vitro experimental confirmation before the LO(V) label is applied. The term "abortive infection" may be used more generally to describe non-productive phage infections that kill bacteria.

PubMed Disclaimer

References

    1. Molineux IJ. Fifty-three years since Hershey and Chase; much ado about pressure but which pressure is it? Virology. 2006;344:221–229. doi: 10.1016/j.virol.2005.09.014. - DOI - PubMed
    1. Kasman LM, Kasman A, Westwater C, Dolan J, Schmidt MG, Norris JS. Overcoming the phage replication threshold: a mathematical model with implications for phage therapy. J Virol. 2002;76:5557–5564. doi: 10.1128/JVI.76.11.5557-5564.2002. - DOI - PMC - PubMed
    1. Abedon ST, Thomas-Abedon C. Phage therapy pharmacology. Curr Pharm Biotechnol. 2010;11:28–47. - PubMed
    1. Abedon ST. Bacteriophages and Biofilms: Ecology, Phage Therapy, Plaques. New York, NY: Nova Science Publishers; 2011.
    1. Abedon ST. Disambiguating bacteriophage pseudolysogeny: an historical analysis of lysogeny, pseudolysogeny, and the phage carrier state. In: Adams HT, editor. Contemporary Trends in Bacteriophage Research. New York, NY: Nova Science Publishers; 2009. pp. 285–307.

LinkOut - more resources